[1]

Moffat JG, Vincent F, Lee JA, Eder J, Prunotto M. 2017. Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nature Reviews Drug Discovery 16:531−543

doi: 10.1038/nrd.2017.111
[2]

Tong X, Qu N, Kong X, Ni S, Zhou J, et al. 2024. Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery. Nature Communications 15:5378

doi: 10.1038/s41467-024-49620-3
[3]

Jia ZC, Yang X, Wu YK, Li M, Das D, et al. 2024. The art of finding the right drug target: emerging methods and strategies. Pharmacological Reviews 76:896−914

doi: 10.1124/pharmrev.123.001028
[4]

Du S, Hu X, Menéndez-Arias L, Zhan P, Liu X. 2024. Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges. Drug Resistance Updates 73:101053

doi: 10.1016/j.drup.2024.101053
[5]

Southey MWY, Brunavs M. 2023. Introduction to small molecule drug discovery and preclinical development. Frontiers in Drug Discovery 3:1314077

doi: 10.3389/fddsv.2023.1314077
[6]

Schuhmacher A, Hinder M, Brief E, Gassmann O, Hartl D. 2025. Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022). Drug Discovery Today 30:104291

doi: 10.1016/j.drudis.2025.104291
[7]

Minikel EV, Painter JL, Dong CC, Nelson MR. 2024. Refining the impact of genetic evidence on clinical success. Nature 629:624−629

doi: 10.1038/s41586-024-07316-0
[8]

Razuvayevskaya O, Lopez I, Dunham I, Ochoa D. 2024. Genetic factors associated with reasons for clinical trial stoppage. Nature Genetics 56:1862−1867

doi: 10.1038/s41588-024-01854-z
[9]

Deng YT, You J, He Y, Zhang Y, Li HY, et al. 2025. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell 188:253−271.e7

doi: 10.1016/j.cell.2024.10.045
[10]

Xu H, Zhao H, Ding C, Jiang D, Zhao Z, et al. 2023. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. Signal Transduction and Targeted Therapy 8:51

doi: 10.1038/s41392-022-01231-4
[11]

Yang X, Zhang B, Wang S, Lu Y, Chen K, et al. 2023. OTTM: an automated classification tool for translational drug discovery from omics data. Briefings in Bioinformatics 24:bbad301

doi: 10.1093/bib/bbad301
[12]

Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, et al. 2024. TTD: therapeutic target database describing target druggability information. Nucleic Acids Research 52:D1465−D1477

doi: 10.1093/nar/gkad751
[13]

Offensperger F, Tin G, Duran-Frigola M, Hahn E, Dobner S, et al. 2024. Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells. Science 384:eadk5864

doi: 10.1126/science.adk5864
[14]

Sun Q, Wang H, Xie J, Wang L, Mu J, et al. 2025. Computer-aided drug discovery for undruggable targets. Chemical Reviews 125:6309−6365

doi: 10.1021/acs.chemrev.4c00969
[15]

Sun D, Gao W, Hu H, Zhou S. 2022. Why 90% of clinical drug development fails and how to improve it? Acta Pharmaceutica Sinica B 12:3049−3062

doi: 10.1016/j.apsb.2022.02.002
[16]

Su W, Hou X. 2024. Targeting active RAS with molecular glue. Pharmaceutical Science Advances 2:100047

doi: 10.1016/j.pscia.2024.100047
[17]

Lessard S, Chao M, Reis K, Beauvais M, Rajpal DK, et al. 2024. Leveraging large-scale multi-omics evidences to identify therapeutic targets from genome-wide association studies. BMC Genomics 25:1111

doi: 10.1186/s12864-024-10971-2
[18]

Jia P, Zhao Z. 2014. Network-assisted analysis to prioritize GWAS results: principles, methods and perspectives. Human Genetics 133:125−138

doi: 10.1007/s00439-013-1377-1
[19]

Wang X, Gulbahce N, Yu H. 2011. Network-based methods for human disease gene prediction. Briefings in Functional Genomics 10:280−293

doi: 10.1093/bfgp/elr024
[20]

Guney E, Oliva B. 2012. Exploiting protein-protein interaction networks for genome-wide disease-gene prioritization. PLoS One 7:e43557

doi: 10.1371/journal.pone.0043557
[21]

Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, et al. 2011. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genetics 7:e1001273

doi: 10.1371/journal.pgen.1001273